Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation

NCT: NCT06051539 · COMPLETED

NCT IDNCT06051539
StatusCOMPLETED
Start Date2023-10-10
Completion2025-10-01

Brief Summary

The purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.

Frequently Asked Questions

What is Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation?

Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation is a clinical trial registered under NCT06051539. Current status: COMPLETED.

What is the status of NCT06051539?

The current status of NCT06051539 (Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation) is: COMPLETED.

When did Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation start?

Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation started on 2023-10-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑